Authorities in China are concerned on slowing domestic demand at the same time as trade tensions mount. Government support of the economy, as well as efforts to defuse trade disputes with the US, are of priority.
Most Popular
Sponsored
REGN's 19% revenue growth & 15% adjusted EPS growth at 16.5 P/E is a buy signal despite Eylea's dip.
AMGN beats Q1 estimates with 5.8% revenue growth & 8% EPS beat. New drugs drive gains, but legacy products face headwinds.
AXSM jumps 22.9% on Alzheimer's drug approval; analysts raise price targets to $255.
PWR beats revenue/EPS estimates, lifts guidance. Strong backlog growth signals robust demand.
Heathrow's £49B runway faces airline pushback over costs; China fund eyes exit amid risk.
ZTS's 9.1% revenue growth & 16.2x P/E show promise; IBM & CSGP face headwinds with soft growth & high P/E.
Amtrak secures $33B infrastructure funds, cutting costs on Baltimore tunnel project to $5B.
Sponsored
Must Read
